The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
The promise and peril of chemical probes
Open accessAbstract
Chemical probes are powerful reagents with increasing impacts on biomedical research. However, probes of poor quality or that are used incorrectly generate misleading results. To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510095 · Cited by 4,366
Self-citationVlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
Hidaka, H., Inagaki, M., Kawamoto, S., & Sasaki, Y. (1984) · Biochemistry · doi:10.1021/bi00316a032 · Cited by 2,688
Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase
Tamaoki, T., Nomoto, H., TAKAHASHI, I., Kato, Y., Morimoto, M., & Tomita, F. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90008-2 · Cited by 2,452
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Prakasam, T., Matosiuk, D., & Jóźwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,933
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Targeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,298
Self-citationDorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y.-F., Bloch, K. D., & Peterson, R. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.54 · Cited by 1,059
Chemistry: Chemical con artists foil drug discovery
Baell, J. B., & Walters, M. A. (2014) · Nature · doi:10.1038/513481a · Cited by 1,048
Self-citationSRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
Zhang, J., Adrián, F., Jahnke, W., Cowan‐Jacob, S. W., Li, A. G., Iacob, R. E., Sim, T., Powers, J. T., Dierks, C., Sun, F., et al. (2010) · Nature · doi:10.1038/nature08675 · Cited by 623
Self-citationLiver X receptors in lipid metabolism: opportunities for drug discovery
Hong, C., & Tontonoz, P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4280 · Cited by 587
Leverson, J. D., Phillips, D. C., Mitten, M. J., Boghaert, E. R., Diaz, D., Tahir, S. K., Belmont, L. D., Nimmer, P., Xiao, Y., Ma, X. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4642 · Cited by 541
Self-citationIdentification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 524
Collins, J. L., Fivush, A. M., Watson, M. A., Galardi, C. M., Lewis, M. C., Moore, L. B., Parks, D. J., Wilson, J. G., Tippin, T. K., Binz, J. G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255116 · Cited by 437
Self-citationTarget validation using chemical probes
Bunnage, M. E., Chekler, E. L. P., & Jones, L. H. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1197 · Cited by 424
Self-citationEdwards, A. M., Isserlin, R., Bader, G. D., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · Nature · doi:10.1038/470163a · Cited by 411
Self-citationFrye, S. V. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.296 · Cited by 381
Self-citationProbing the Probes: Fitness Factors For Small Molecule Tools
Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 304
Self-citationRecognizing and exploiting differences between RNAi and small-molecule inhibitors
Weiss, W. A., Taylor, S. S., & Shokat, K. M. (2007) · Nature Chemical Biology · doi:10.1038/nchembio1207-739 · Cited by 294
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
Workman, P., Clarke, P., Raynaud, F., & van Montfort, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4355 · Cited by 287
Self-citationClark, K., MacKenzie, K. F., Petkevicius, K., Kristariyanto, Y. A., Zhang, J., Choi, H. G., Peggie, M. W., Plater, L., Pedrioli, P. G. A., McIver, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215450109 · Cited by 260
Self-citationThe specificities of small molecule inhibitors of the TGFß and BMP pathways
Vogt, J., Traynor, R., & Sapkota, G. P. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.019 · Cited by 256
Determining target engagement in living systems
Simon, G. M., Niphakis, M. J., & Cravatt, B. F. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1211 · Cited by 245
Self-citationThe human genome and drug discovery after a decade. Roads (still) not takenPreprint
Isserlin, R., Bader, G. D., Edwards, A. M., Frye, S. V., Willson, T. M., & Yu, F. H. (2011) · arXiv (Cornell University) · doi:10.48550/arxiv.1102.0448 · Cited by 236
Self-citationAhn, K., Smith, S. E., Liimatta, M. B., Beidler, D. R., Sadagopan, N., Dudley, D. T., Young, T., Wren, P. B., Zhang, Y., Swaney, S. M., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180257 · Cited by 232
Self-citationDifferent forms of cell death induced by putative BCL2 inhibitors
Vogler, M., Weber, K., Dinsdale, D. D., Schmitz, I., Schulze‐Osthoff, K., Dyer, M. J. S., & Cohen, G. M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.48 · Cited by 203
Liu, X., Shi, Y., Maag, D., Palma, J. P., Patterson, M. J. S., Ellis, P. A., Surber, B. W., Ready, D. B., Soni, N. B., Ladror, U. S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1973 · Cited by 174
Glazer, R. I., Hartman, K. D., Knode, M. C., Richard, M. M., Chiang, P. K., Tseng, C. K. H., & Márquez, V. E. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90048-3 · Cited by 157
BET bromodomain inhibitors: a patent review
Garnier, J., Sharp, P. P., & Burns, C. J. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.859244 · Cited by 122
Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases
Cherblanc, F., Chapman, K. L., Brown, R. E., & Fuchter, M. J. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1187 · Cited by 114
Colloidal Aggregation Causes Inhibition of G Protein-Coupled Receptors
Sassano, M. F., Doak, A. K., Roth, B. L., & Shoichet, B. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301749y · Cited by 110
Self-citationOn the Histone Lysine Methyltransferase Activity of Fungal Metabolite Chaetocin
Cherblanc, F., Chapman, K. L., Reid, J., Borg, A. J., Sundriyal, S., Alcázar‐Fuoli, L., Bignell, E., Demetriades, M., Schofield, C. J., DiMaggio, P. A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401063r · Cited by 56
Pinelli, A., Godio, C., Laghezza, A., Mitro, N., Fracchiolla, G., Tortorella, V., Lavecchia, A., Novellino, E., Fruchart, J., Staels, B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0502844 · Cited by 52
Recently targeted kinases and their inhibitors—the path to clinical trials
Knapp, S., & Sundström, M. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.015 · Cited by 50
Self-citationTarget (In)Validation: A Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry
Sweis, R. F. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00183 · Cited by 29
The frequency of Mislabelled chemicals from commercial suppliers
Zeiger, E., Prokopetz, A. T., & Walters, D. B. (1993) · Accountability in Research · doi:10.1080/08989629308573829 · Cited by 4
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Roth, B. L. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.040 · Cited by 1,742
Self-citationCounting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,228
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Moffat, J. G., Vincent, F., Lee, J. A., Eder, J., & Prunotto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.111 · Cited by 939
Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913
Metadata
- Authors
- Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., Buser-Doepner, C., Campbell, R. M., Carter, A. J., Cohen, P., Copeland, R. A., Cravatt, B., Dahlin, J. L., Dhanak, D., Edwards, A. M., Frederiksen, M., Frye, S. V., Gray, N., Grimshaw, C. E., Hepworth, D., Howe, T., Huber, K. V. M., Jin, J., Knapp, S., Kotz, J. D., Kruger, R. G., Lowe, D., Mader, M. M., Marsden, B., Mueller-Fahrnow, A., Müller, S., O'Hagan, R. C., Overington, J. P., Owen, D. R., Rosenberg, S. H., Ross, R., Roth, B., Schapira, M., Schreiber, S. L., Shoichet, B., Sundström, M., Superti-Furga, G., Taunton, J., Toledo-Sherman, L., Walpole, C., Walters, M. A., Willson, T. M., Workman, P., Young, R. N., & Zuercher, W. J.
- Affiliations
- University of Toronto (CA)
- Constellation Pharmaceuticals (United States) (US)
- National Institutes of Health (US)
- Monash University (AU)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Institute of Cancer Research (GB)
- University of Oxford (GB)
- Structural Genomics Consortium (CA)
- Pfizer (United States) (US)
- Eli Lilly (United States) (US)
- Boehringer Ingelheim (Germany) (DE)
- University of Dundee (GB)
- Epizyme (United States) (US)
- Scripps Research Institute (US)
- Mayo Clinic (US)
- Novartis (Switzerland) (CH)
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Janssen (United Kingdom) (GB)
- Austrian Academy of Sciences (AT)
- Icahn School of Medicine at Mount Sinai (US)
- Broad Institute (US)
- GlaxoSmithKline (United States) (US)
- Vertex Pharmaceuticals (United States) (US)
- European Bioinformatics Institute (GB)
- AbbVie (United States) (US)
- University of California, San Francisco (US)
- Karolinska University Hospital (SE)
- Howard Hughes Medical Institute (US)
- University of Minnesota (US)
- Simon Fraser University (CA)
- Corresponding author
- Edwards, Aled M
- ORCID
- Arrowsmith, Cheryl H
- Audia, James E
- Austin, Christopher
- Baell, Jonathan
- Blagg, Julian
- Bountra, Chas
- Brennan, Paul E
- Brown, Peter J
- Bunnage, Mark E
- Campbell, Robert M
- Carter, Adrian J
- Cohen, Philip
- Copeland, Robert A
- Dahlin, Jayme L
- Edwards, Aled M
- Frederiksen, Mathias
- Frye, Stephen V
- Gray, Nathanael
- Grimshaw, Charles E
- Hepworth, David
- Huber, Kilian V M
- Jin, Jian
- Knapp, Stefan
- Kotz, Joanne D
- Mader, Mary M
- Marsden, Brian
- Müller, Susanne
- Overington, John P
- Owen, Dafydd R
- Ross, Ruth
- Roth, Bryan
- Schapira, Matthieu
- Schreiber, Stuart L
- Shoichet, Brian
- Sundström, Michael
- Taunton, Jack
- Walters, Michael A
- Willson, Timothy M
- Workman, Paul
- Young, Robert N
- Zuercher, William J
- Venue
- Nature Chemical Biology
- Published
- 2015-07-21
- Volume
- 11
- Issue
- 8
- Pages
- 536-541
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC4706458
- OpenAlex
- W1516646538
- Cited by
- 839
- References
- 41
- Citations by year
- 2026: 37 · 2025: 57 · 2024: 62 · 2023: 67 · 2022: 67 · 2021: 81 · 2020: 86 · 2019: 75 · 2018: 79 · 2017: 98 · 2016: 103 · 2015: 25
- FWCI
- 48.56
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-10-20)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Chemical Biology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- Deakin Research Online (Deakin University) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- UNC Libraries
- Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Harvard University
- University of Dundee
- Wellcome Trust (106169/Z/14/Z, 104104, 106169, 104104/A/14/Z, 100294)
- Constellation Pharmaceuticals
- Cancer Research UK (11566)
- University of Oxford
- Monash University
- Österreichischen Akademie der Wissenschaften
- University of Toronto
- National Institutes of Health
- University of North Carolina at Chapel Hill
- Novartis Institutes for BioMedical Research
- Medical Research Council (MR/K000985/1)
- National Institute of General Medical Sciences (R01GM103893)
- Janssen Research and Development
- National Center for Advancing Translational Sciences
- UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- chemical probes, best practices, wikis, research reproducibility, chemical biology
- MeSH terms
- Humans, Molecular Weight, Sensitivity and Specificity, Molecular Probes, Intellectual Property, Internet, Information Dissemination, Biomedical Research, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
